Exelixis (EXEL) Interest Coverage Ratio Growth (1y) (2011 - 2017)
Powered by 
Analysis
Exelixis (EXEL) Interest Coverage Ratio Growth (1y) (2011 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -176.09% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 93.04% |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -53.46% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 99.48% |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 364.69% |
| Mar 31, 2017 | 195.64% |
| Sep 30, 2016 | 126.01% |
| Jun 30, 2016 | 8.05% |
| Mar 31, 2016 | -160.21% |
| Sep 30, 2015 | 15.10% |
| Jun 30, 2015 | 48.78% |
| Mar 31, 2015 | 66.79% |
| Dec 31, 2014 | 25.09% |
| Sep 30, 2014 | 14.16% |
| Jun 30, 2014 | -11.88% |
| Mar 31, 2014 | -79.63% |
| Dec 31, 2013 | -152.63% |
| Sep 30, 2013 | -47.64% |
| Jun 30, 2013 | 42.93% |
| Mar 31, 2013 | 44.76% |
| Dec 31, 2012 | -136.25% |
| Sep 30, 2012 | -117.22% |
| Jun 30, 2012 | -84.91% |
| Mar 31, 2012 | 7.47% |